Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis.
Naoki MiyazakiToshiki IwasakiHitomi SakaiRurina WatanukiYoshinori TanizawaZhihong CaiTsutomu KawaguchiJunji TsurutaniKengo NagashimaPublished in: Current medical research and opinion (2024)
Identified risk factors were consistent with the previous reports, and this study provides quantitative summary of risk factors for HR+/HER2- early breast cancer recurrence in Japan. (PROSPERO Registration ID, CRD42022338391.).